1960
DOI: 10.1111/j.1532-5415.1960.tb00410.x
|View full text |Cite
|
Sign up to set email alerts
|

Iproniazid in the Treatment of Resistant Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

1967
1967
2017
2017

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 15 publications
0
1
0
1
Order By: Relevance
“…Only one, pargyline hydrochloride, has come into clinical use. Favourable results with this compound have been reported in particular from the U.S.A. (1, 3,9,12,17,18,20).…”
mentioning
confidence: 72%
“…Only one, pargyline hydrochloride, has come into clinical use. Favourable results with this compound have been reported in particular from the U.S.A. (1, 3,9,12,17,18,20).…”
mentioning
confidence: 72%
“…Os primeiros relatos de formas de apresentação da HAS em que o paciente não atingia um controle pressórico adequado, a despeito de toda terapia anti-hipertensiva existente, datam da década de 50. Inicialmente esse grupo portador de hipertensão de difícil controle também era denominado hipertenso refratário 25 ou hipertenso resistente 26 . Em 2008, as terminologias "hipertensão de difícil controle", "hipertensão arterial resistente" e "hipertensão refratária" coexistiam na literatura.…”
Section: Hipertensão Arterial Resistente (Har)unclassified